These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28875464)

  • 1. Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia.
    Kanchanatawan B; Hemrungrojn S; Thika S; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Maes M
    Mol Neurobiol; 2018 Jun; 55(6):5184-5201. PubMed ID: 28875464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Schizophrenia, Depression, Anxiety, and Physiosomatic Symptoms Are Strongly Related to Psychotic Symptoms and Excitation, Impairments in Episodic Memory, and Increased Production of Neurotoxic Tryptophan Catabolites: a Multivariate and Machine Learning Study.
    Kanchanatawan B; Thika S; Sirivichayakul S; Carvalho AF; Geffard M; Maes M
    Neurotox Res; 2018 Apr; 33(3):641-655. PubMed ID: 29380275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation.
    Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Maes M
    Mol Neurobiol; 2018 Mar; 55(3):2214-2226. PubMed ID: 28290151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: results of supervised machine learning.
    Kanchanatawan B; Sriswasdi S; Thika S; Sirivichayakul S; Carvalho AF; Geffard M; Kubera M; Maes M
    Metab Brain Dis; 2018 Aug; 33(4):1053-1067. PubMed ID: 29527624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs.
    Kanchanatawan B; Sirivichayakul S; Carvalho AF; Anderson G; Galecki P; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):205-216. PubMed ID: 28690204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid.
    Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Ormstad H; Anderson G; Maes M
    Mol Neurobiol; 2018 Feb; 55(2):1524-1536. PubMed ID: 28181189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Episodic memory and delayed recall are significantly more impaired in younger patients with deficit schizophrenia than in elderly patients with amnestic mild cognitive impairment.
    Kanchanatawan B; Tangwongchai S; Supasitthumrong T; Sriswasdi S; Maes M
    PLoS One; 2018; 13(5):e0197004. PubMed ID: 29763451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway.
    Kanchanatawan B; Sirivichayakul S; Thika S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Noto C; Ivanova R; Maes M
    Metab Brain Dis; 2017 Aug; 32(4):1003-1016. PubMed ID: 28258445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Schizophrenia Model: Immune Activation is Associated with the Induction of Different Neurotoxic Products which Together Determine Memory Impairments and Schizophrenia Symptom Dimensions.
    Sirivichayakul S; Kanchanatawan B; Thika S; Carvalho AF; Maes M
    CNS Neurol Disord Drug Targets; 2019; 18(2):124-140. PubMed ID: 30451122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Tryptophan Catabolites on Negative Symptoms and Deficit Schizophrenia are Partly Mediated by Executive Impairments: Results of Partial Least Squares Path Modeling.
    Kanchanatawan B; Maes M
    CNS Neurol Disord Drug Targets; 2018; 17(6):473-486. PubMed ID: 29968545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia.
    Kanchanatawan B; Sriswasdi S; Maes M
    Metab Brain Dis; 2019 Feb; 34(1):267-282. PubMed ID: 30467771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome.
    Roomruangwong C; Kanchanatawan B; Sirivichayakul S; Anderson G; Carvalho AF; Duleu S; Geffard M; Maes M
    Mol Neurobiol; 2017 May; 54(4):3038-3049. PubMed ID: 27037573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakdown of the Paracellular Tight and Adherens Junctions in the Gut and Blood Brain Barrier and Damage to the Vascular Barrier in Patients with Deficit Schizophrenia.
    Maes M; Sirivichayakul S; Kanchanatawan B; Vodjani A
    Neurotox Res; 2019 Aug; 36(2):306-322. PubMed ID: 31077000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In (deficit) schizophrenia, a general cognitive decline partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and quality of life.
    Maes M; Kanchanatawan B
    CNS Spectr; 2021 Apr; ():1-10. PubMed ID: 33843548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Thai version of the short Boston Naming Test (T-BNT) in patients with Alzheimer's dementia and mild cognitive impairment: clinical and biomarker correlates.
    Aniwattanapong D; Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Tawankanjanachot I; Chuchuen P; Snabboon T; Carvalho AF; Maes M
    Aging Ment Health; 2019 Jul; 23(7):840-850. PubMed ID: 30351202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Schizophrenia, Increased Plasma IgM/IgA Responses to Gut Commensal Bacteria Are Associated with Negative Symptoms, Neurocognitive Impairments, and the Deficit Phenotype.
    Maes M; Kanchanatawan B; Sirivichayakul S; Carvalho AF
    Neurotox Res; 2019 Apr; 35(3):684-698. PubMed ID: 30552634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments.
    Almulla AF; Vasupanrajit A; Tunvirachaisakul C; Al-Hakeim HK; Solmi M; Verkerk R; Maes M
    Mol Psychiatry; 2022 Sep; 27(9):3679-3691. PubMed ID: 35422466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression.
    Anderson G; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():5-19. PubMed ID: 22800757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a new classification of stable phase schizophrenia into major and simple neuro-cognitive psychosis: Results of unsupervised machine learning analysis.
    Kanchanatawan B; Sriswasdi S; Thika S; Stoyanov D; Sirivichayakul S; Carvalho AF; Geffard M; Maes M
    J Eval Clin Pract; 2018 Aug; 24(4):879-891. PubMed ID: 29790237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde.
    Maes M; Sirivichayakul S; Kanchanatawan B; Carvalho AF
    World J Biol Psychiatry; 2020 Jun; 21(5):383-401. PubMed ID: 32031479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.